Works by Li, Shuofeng


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04085-1
    By:
    • Li, Shuofeng;
    • Yu, Guanhua;
    • Wang, Mingming;
    • Feng, Shi;
    • Wang, Shanshan;
    • Piao, Mingjian;
    • Li, Chengjie;
    • Zhou, Zixiang;
    • Xun, Ziyu;
    • Sun, Boyu;
    • Li, Jiongyuan;
    • Zhang, Nan;
    • Li, Hu;
    • Yang, Xiaobo;
    • Zhu, Zhenyu;
    • Zhao, Haitao
    Publication type:
    Article
    17

    Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04085-1
    By:
    • Li, Shuofeng;
    • Yu, Guanhua;
    • Wang, Mingming;
    • Feng, Shi;
    • Wang, Shanshan;
    • Piao, Mingjian;
    • Li, Chengjie;
    • Zhou, Zixiang;
    • Xun, Ziyu;
    • Sun, Boyu;
    • Li, Jiongyuan;
    • Zhang, Nan;
    • Li, Hu;
    • Yang, Xiaobo;
    • Zhu, Zhenyu;
    • Zhao, Haitao
    Publication type:
    Article
    18
    20
    21
    22
    23
    24
    25
    26
    27